Providence Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $483K | Buy |
619
+117
| +23% | +$91.2K | 0.09% | 113 |
|
2025
Q1 | $415K | Sell |
502
-5
| -1% | -$4.13K | 0.09% | 106 |
|
2024
Q4 | $391K | Buy |
507
+17
| +3% | +$13.1K | 0.08% | 104 |
|
2024
Q3 | $434K | Hold |
490
| – | – | 0.09% | 102 |
|
2024
Q2 | $444K | Buy |
490
+7
| +1% | +$6.34K | 0.1% | 99 |
|
2024
Q1 | $376K | Hold |
483
| – | – | 0.08% | 100 |
|
2023
Q4 | $282K | Sell |
483
-5
| -1% | -$2.92K | 0.07% | 105 |
|
2023
Q3 | $262K | Buy |
488
+5
| +1% | +$2.69K | 0.07% | 109 |
|
2023
Q2 | $227K | Hold |
483
| – | – | 0.06% | 109 |
|
2023
Q1 | $166K | Hold |
483
| – | – | 0.04% | 107 |
|
2022
Q4 | $177K | Buy |
+483
| New | +$177K | 0.05% | 111 |
|
2022
Q2 | – | Sell |
-10
| Closed | -$3K | – | 388 |
|
2022
Q1 | $3K | Buy |
+10
| New | +$3K | ﹤0.01% | 310 |
|